SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-18-057600
Filing Date
2018-09-19
Accepted
2018-09-19 16:06:55
Documents
40
Period of Report
2018-09-19

Document Format Files

Seq Description Document Type Size
1 6-K a18-16320_16k.htm 6-K 545076
  Complete submission text file 0001104659-18-057600.txt   2791974

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT fwp-20180630.xml EX-101.INS 518298
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fwp-20180630.xsd EX-101.SCH 39772
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fwp-20180630_cal.xml EX-101.CAL 46082
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fwp-20180630_def.xml EX-101.DEF 81794
6 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT fwp-20180630_lab.xml EX-101.LAB 278262
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fwp-20180630_pre.xml EX-101.PRE 177894
Mailing Address OSTERGADE 24A, 1 COPENHAGEN G7 1100
Business Address OSTERGADE 24A, 1 COPENHAGEN G7 1100 0114533444242
Forward Pharma A/S (Filer) CIK: 0001604924 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36686 | Film No.: 181077819
SIC: 2834 Pharmaceutical Preparations